📉 The Financial Deep Dive
Cholamandalam Investment and Finance Company Limited (CIFCL) has posted impressive unaudited financial results for the quarter and nine months ended December 31, 2025.
The Numbers:
- Consolidated Profit After Tax (PAT) for Q3 FY26 climbed 18.5% YoY to ₹1,289.97 Crores, up from ₹1,088.21 Crores in Q3 FY25. For the nine-month period, PAT increased by 19.5% YoY to ₹3,587.41 Crores.
- Total Income for the consolidated entity in Q3 FY26 registered a 17.1% YoY growth, reaching ₹8,008.68 Crores compared to ₹6,836.60 Crores. Nine-month total income grew 20.9% YoY to ₹22,975.19 Crores.
- Assets Under Management (AUM) saw a significant 20% year-on-year expansion, totaling ₹2,27,770 Crores as of December 31, 2025. Key segments like Loan Against Property (LAP) and Secured Business and Personal Loans (SBPL) demonstrated exceptional growth, with AUM increasing by 31% and 52% YoY, respectively.
The Quality:
- The company's Capital Adequacy Ratio (CAR) remains robust at 19.16%, comfortably exceeding the regulatory minimum of 15%, indicating strong capitalisation.
- Return on Equity (ROE) for the quarter stood at a healthy 19.11%.
- Asset quality metrics, while showing slight sequential increases, remain within manageable levels: Stage 3 assets were 3.36% and Gross NPA stood at 4.63% as of December 31, 2025.
- An increase in employee benefits expense by ₹49.65 Crores (Consolidated) was noted due to the implementation of New Labour Codes, impacting short-term profitability but is a regulatory compliance cost.
The Forward View & Discussion:
- The Board of Directors' approval of a 65% interim dividend (₹1.30 per equity share) signals confidence in sustained profitability and a commitment to shareholder returns.
- The strong AUM growth, particularly in high-potential segments like LAP and SBPL, positions the company well for future expansion.
🚩 Risks & Outlook
While growth remains strong, the marginal uptick in Stage 3 assets and Gross NPAs warrants monitoring. The increased employee costs are a one-off impact from regulatory changes. The company's prudent capitalisation and robust AUM growth are positive indicators for the near to medium term.
